XT
OMGA

XTX Topco’s Omega Therapeutics, Inc. Common Stock OMGA Stock Holding History

XTX Topco’s Portfolio OMGA Stock Details OMGA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-32,253
Closed -$39.3K – 3081
2024
Q3 		$39.3K Sell
32,253
-51,686
-62% -$82.3K ﹤0.01% 1729
2024
Q2 		$174K Buy
+83,939
New +$198K 0.01% 1292

Other funds holding OMGA

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HP
Harbourvest Partners Boston, Massachusetts $101M AUM 38.13% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
7IH
72 Investment Holdings Stamford, Connecticut $49.6M AUM 684.72% 1-Year Est. Return

XTX Topco's OMGA Position: Q4 2024 in Review

XTX Topco sold out of Omega Therapeutics, Inc. Common Stock (OMGA) in Q4 2024, closing a stake of 32,253 shares — an estimated $39.3K sold.

XTX Topco first reported a position in OMGA in Q2 2024 and held it in 2 quarters. The position peaked at $174K in Q2 2024. 53 funds tracked by Wall St. Rank hold OMGA as of Q4 2024.

  • XTX Topco reported no remaining Omega Therapeutics, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • XTX Topco sold 32,253 Omega Therapeutics, Inc. Common Stock shares in Q4 2024, an estimated $39.3K.
  • XTX Topco first reported a position in Omega Therapeutics, Inc. Common Stock in Q2 2024 and held it in 2 quarters.
  • XTX Topco's Omega Therapeutics, Inc. Common Stock position peaked at $174K in Q2 2024.
  • 53 funds tracked by Wall St. Rank held Omega Therapeutics, Inc. Common Stock as of Q4 2024.

Based on XTX Topco's 13F filing for Q4 2024, filed 13 Feb 2025.